RESUMO
In this work we compared the results of the GSNO determination in human plasma by two independent methods. The first method is based on the pre-column derivatization of GSNO thiolic part by p-hydroxymercury benzoate (PHMB) and followed by the determination of GS-PHMB product by reversed phase chromatography coupled to chemical vapour generation atomic fluorescence spectrometry (RPC-CVGAFS). The second method is based on RPC separation of GSNO from interfering compounds and the post-column, on-line enzymatic hydrolysis of GSNO by commercial gamma-glutamyl transferase (GGT) and fluorescence detection. Endogenous GSNO was determined only in plasma from blood sampled by syringe (not by Vacutainers) and ranged between 157 and 257nM on the basis of RPC-CVGAFS method, and between 90 and 225nM by RPC-FD method. There was a good correlation between the two methods (slope=1.06+/-0.09, R(2)=0.9543). RPC-CVGAFS method based on PHMB derivatization determined a GSNO concentration 60+/-20nM in excess with respect to RPC-FD method. Sampling issues connected with common blood sampling procedures like venipuncture and sampling in syringe or Vacutainers still introduce in GSNO analysis unknown factors, which require further investigations.